Why the study?
Does biliopancreatic diversion improve metabolic and cardiovascular functions in a severely obese patient?
Does biliopancreatic diversion improve metabolic and cardiovascular functions in a severely obese patient?
Biliopancreatic diversion with duodenal switch can provide significant metabolic and cardiovascular benefits, including improved left ventricular diastolic function, in severely obese patients.
Case suggests biliopancreatic diversion may improve cardiac function in severe obesity; hypothesis-generating and requires controlled trials.
BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duodenal switch reduces efficiently excess body weight and improves metabolic and cardiovascular functions. CASE PRESENTATION: A 56-year-old man with severe clinical obesity underwent a biliopancreatic diversion with a duodenal switch after unsuccessful treatment with weight loss pharmacotherapy. He had diabetes, hypertension and sleep apnea syndrome and was on three medications for hypertension and two hypoglycemic agents in addition to > 200 insulin units daily. Eleven months after the surgery, he had lost 40% of his body weight. The lipid profile showed great improvement and the hypertension and diabetes were more easily controlled with no more insulin needed. The pseudonormalized pattern of left ventricular diastolic function improved and ventricular walls showed decreased thickness. CONCLUSION: Biliopancreatic diversion may bring metabolic and cardiovascular benefits in severely obese patients from a cardiovascular perspective.
No takes yet. Share an insight, caveat, or question.
Woods et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: